European equities traded in the US as American depositary receipts kicked off the week on a down note Monday morning, falling 0.87% to 1,321.99 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biotech firm BioNTech (BNTX), which rose 3.3% and 2.7% respectively. They were followed by telecommunication companies Ericsson (ERIC) and Telefonica (TEF) and, which were up 1.1% and 0.7% respectively.
The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and semiconductor company Sequans Communications (SQNS), which lost 9.5% and 4.7% respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which dropped 4% and 3.2% respectively.
From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which advanced 4.2% and 3.2% respectively. They were followed by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma Group (MREO), which rose 3.9% and 3.5% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which fell 4.5% and 3.8% respectively. They were followed by cruise line operator Carnival (CUK) and biotech firm Trinity Biotech (TRIB), which were down 3% and 2.3% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。